fda warning letter compounded semaglutide september 2025 Last month, the issued 25 letters to telehealth companies over what it called false or misleading claims about GLP-1 medications Article: Brazilian Clinics and the

Indian J Gastroenterol, 2025

Constipation Constipation is a common side effect of semaglutide, reported in about 24% of people taking the injectable form in clinical trials

This applies across private plans, Medicaid (which varies by state), and Medicare (which may cover semaglutide for type 2 diabetes but is currently prohibited from covering weight loss medications altogether)

p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability

Mean baseline HbA 1c was 7.3%, indicating that T2D was well controlled in the study population

Provide the name and dose of your oral contraceptive if you use one, and note whether you've experienced any irregular bleeding or contraceptive failures in the past